• GSK, Immatics team up for cancer cell therapies pharmatimes
    March 10, 2020
    Immatics Biotechnologies has announced a new strategic collaboration with GlaxoSmithKline (GSK), in order to develop novel adoptive cell therapies targeting multiple cancer indications.
PharmaSources Customer Service